Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

12.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.7K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

160
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
160
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

143
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
143
T Cell Types and Functions01:24

T Cell Types and Functions

3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

10.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Autoimmune Disorders01:29

Autoimmune Disorders

2.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple Intracerebral Hemorrhages in an Old Patient with Rheumatoid Arthritis.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2016
Same author

New insight into the rheumatoid vasculitis.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2015
Same author

Rheumatoid arthritis and ischemic strokes in a young woman. Are these conditions interrelated?

Romanian journal of internal medicine = Revue roumaine de medecine interne·2015
Same author

The human microbiome in autoimmune diseases.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2015
Same author

Ischemic strokes in a young patient with dermatomyositis, systemic lupus erythematosus and secondary antiphospholipid syndrome mimicking herpetic encephalitis.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2014
Same author

The role of heavy metals in autoimmunity.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2014

Related Experiment Video

Updated: May 5, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.5K

Genetic differences between patients with rheumatoid arthritis.

M Cojocaru1, B Chicoş

  • 1"Titu Maiorescu" University, Faculty of Medicine, Bucharest, Romania. mancojocaru@yahoo.com

Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne
|December 4, 2013
PubMed
Summary

Rheumatoid arthritis (RA) is a common inflammatory joint disease influenced by genetic factors. Research into these genetic risks, including major histocompatibility complex (MHC) and non-HLA genes, is crucial for understanding RA pathogenesis and developing treatments.

More Related Videos

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

6.0K

Related Experiment Videos

Last Updated: May 5, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.5K
Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

6.0K

Area of Science:

  • Immunology
  • Genetics
  • Rheumatology

Background:

  • Rheumatoid arthritis (RA) is a prevalent chronic inflammatory joint disease.
  • Genetic predisposition is a key factor in RA development.
  • Understanding the preclinical phase is vital for elucidating gene-environment interactions.

Purpose of the Study:

  • To review current data on genetic susceptibility factors for rheumatoid arthritis.
  • To highlight the roles of both MHC and non-HLA genes in RA pathogenesis.
  • To emphasize the need for identifying non-HLA genes and their clinical relevance.

Main Methods:

  • Review of existing literature on genetic factors in RA.
  • Analysis of studies confirming polygenic contribution, including MHC and non-HLA genes.
  • Synthesis of evidence regarding specific gene associations and their impact.

Main Results:

  • The major histocompatibility complex (MHC) significantly contributes to RA susceptibility.
  • HLA genes account for only part of the genetic risk; non-HLA genes are also implicated.
  • Specific MHC alleles are associated with RA pathogenesis, and non-HLA gene identification is ongoing.

Conclusions:

  • Genetic factors, including MHC and non-HLA genes, play a critical role in RA susceptibility and pathogenesis.
  • Further research into genetic factors, particularly non-HLA genes and those affecting disease severity, is essential.
  • Identifying these genetic correlates holds promise for clinically relevant outcomes in RA management.